IP Library Granted Patent US 7,091,000
Granted Patent B2
US 7,091,000 · App. 10/361,522 · Granted Aug 15, 2006

Bacterial strains which overproduce riboflavin and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,091,000
App. No.
10/361,522
Granted
Aug 15, 2006
Kind
B2
Abstract

Vectors and recombinant bacteria for overproducing riboflavin, in which nucleic acid overproducing riboflavin biosynthetic proteins is introduced in the chromosome of the host organism, e.g. at multiple sites and in multiple copies per site. A rib operon having at least five genes is used to make such recombinant bacteria.

Claims (11)

1. A method for producing a polypeptide that has ORF5 activity and is in the riboflavin biosynthetic pathway comprising:

(a) providing an isolated polynucleotide template comprising a bacterial rib operon which includes a bacterial ORF5 structural gene and an exogenous promoter, the ORF5 structural gene being hybridizable to B. subtilis rib ORF5 and encoding a polypeptide that has ORF5 activity, wherein the promoter is positioned such that it promotes transcription of the ORF5 structural gene;

(b) carrying out transcription and translation on the polynucleotide template to produce a polypeptide that has ORF5 activity; and

(c) recovering the polypeptide.

2. The method according to claim 1 wherein step (b) comprises coupled transcription and translation.

3. The method according to claim 1 , wherein step (b) comprises in vitro coupled transcription and translation.

4. The method according to claim 1 , wherein step (b) comprises carrying out in vitro coupled transcription and translation with an S-30 fraction kit.

5. The method according to claim 1 , further comprising isolating the polypeptide on an SDS polyacrylamide gel.

6. The method according to claim 1 , wherein the ORF5 structural gene comprises nucleotides 1101–2183 of SEQ ID NO:1.

7. The method according to claim 6 , wherein the ORF5 structural gene consists of nucleotides 1101–2183 of SEQ ID NO:1.

8. The method according to claim 1 , wherein the ORF5 structural gene consists of a nucleotide sequence that encodes a polypeptide comprising amino acid residues 346–706 of SEQ ID NO:5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2004
From: ROCHE VITAMINS INC.
To: DSM NUTRITIONAL PRODUCTS, INC.
Reel/Frame 015452/0973 →